Innate Pharma S.A. Sponsored ADR (IPHA) vs Oramed Pharmaceuticals Inc. (ORMP)
- Innate Pharma S.A. Sponsored ADR IPHA 1.43 −3.38%
- Oramed Pharmaceuticals Inc. ORMP 4.07 −2.63%
Innate Pharma S.A. Sponsored ADR and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and Oramed Pharmaceuticals Inc. are of similar size ($173.9M and $165.3M). Innate Pharma S.A. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.0×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 347.8% against −4.17%. Oramed Pharmaceuticals Inc. has the higher net margin (0.00% vs −99.7%) and the lower return on invested capital (−3.40% vs 0.00%). Across the 14 metrics below, Oramed Pharmaceuticals Inc. leads on 9 and Innate Pharma S.A. Sponsored ADR on 5.
Valuation
Profitability
| Metric | IPHA | ORMP | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 32.31% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (99.70%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 73.90% | (56.36%) |
| Return on assets | 0.00% | 65.52% | (48.04%) |
| Return on invested capital | 0.00% | (3.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack